Stock listing

NASDAQ:ADVM Adverum Biotechnologies Inc Stock

Follow Adverum Biotechnologies Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ADVM

$4.36 USD

Close on Dec 9, 2025 · No longer trades

Mar 21, 2024 to last close -70.4% · weekly closes, Mar 21, 2024 – Dec 9, 2025
Lowest – highest close
$2.05 – $16.06 USDSince Mar 21, 2024 · lowest May 15, 2025 · highest Mar 22, 2024

Delisted NASDAQ:ADVM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ADVM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Adverum Biotechnologies Inc on 6ix

Calls
1 call with a replay · 1 with a transcript · latest Mar 1, 2021
Decks
11 decks · latest Dec 4, 2025

Events

CallWhenStatus
Adverum Biotechnologies (ADVM) Q4 2020 Earnings CallMon, Mar 01, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
FLORetina December 2025Conference19 slidesDec 4, 2025
Technical Presentation (November 2024)Technical78 slidesNov 18, 2024
Corporate Update (July 2024)Corporate update39 slidesJul 17, 2024
Technical Presentation (February 2024)Technical32 slidesFeb 8, 2024
Proxy Contest (April 2021)Proxy contest10 slidesApr 26, 2021
Proxy Contest (April 2021)Proxy contest65 slidesApr 22, 2021
Q4 2020 Earnings PresentationEarnings22 slidesMar 1, 2021
Investor Presentation (October 2016)Investor deck15 slidesOct 13, 2016
Avalanche Biotechnologies — Merger or Acquisition (March 2016)Merger or acquisition36 slidesMar 10, 2016
Avalanche Biotechnologies — Merger or Acquisition (February 2016)Merger or acquisition34 slidesFeb 22, 2016
All 11 decks
DeckKindSlidesDate
Avalanche Biotechnologies — Merger or Acquisition (February 2016)Merger or acquisition42 slidesFeb 17, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Patrick Machado
Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Turning Point Therapeutics Inc (Director · May 13, 2019 – Aug 17, 2022 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past)
Director · Since at least Mar 14, 2017
Dawn Svoronos
Other companies: Xenon Pharmaceuticals Inc. (Director · Since at least Sep 27, 2016); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Global Blood Therapeutics Inc (Director · Dec 19, 2018 – Oct 5, 2022 · Past); Endocyte Inc (Director · May 3, 2018 – Dec 21, 2018 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2016 – Jun 9, 2022 · Past); Medivation Inc (Director · Apr 22, 2013 – Sep 28, 2016 · Past)
Director · Since at least Dec 9, 2020
Linda Bain
Other companies: Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); Autolus Therapeutics plc (Chair of the Audit Committee, Member of the Nominating and Governance Committee · Since at least Mar 18, 2026); Arvinas, Inc. (Director · Since at least Jun 10, 2020); VBI Vaccines Inc. (Director · Jul 1, 2021 – Jan 27, 2022 · Past); Codiak BioSciences Inc (Chief Financial Officer · Oct 13, 2020 – Mar 28, 2023 · Past); Bluebird bio Inc (VP, Fin. & Business Operations · Jun 18, 2013 – Feb 26, 2014 · Past)
Chief Financial Officer · Jul 30, 2014 – Aug 21, 2015 · Past
Mitchell H Finer
Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Feb 13, 2019 · Past); Bluebird bio Inc (Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past)
Director · May 11, 2016 – Jul 31, 2019 · Past
Amber Salzman
Other companies: Akcea Therapeutics Inc (Director · Feb 12, 2020 – Oct 12, 2020 · Past)
President and CEO, Director · May 11, 2016 – Feb 15, 2018 · Past
C. David Nicholson
Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Director · Since at least Dec 28, 2023)
Director · Since at least Nov 3, 2023
Hans Hull
Other companies: Pliant Therapeutics, Inc. (Chief Business Officer · Jun 2, 2020 – Jan 23, 2025 · Past)
Chief Executive Officer · Jul 30, 2014 – Aug 21, 2015 · Past
Reed V. Tuckson
Other companies: Henry Schein, Inc. (Director · Since at least Mar 1, 2024)
Director · Since at least Jun 17, 2024
Samuel B Barone
Other companies: Disc Medicine, Inc. (Chief Medical Officer · Apr 12, 2021 – Apr 12, 2021 · Past)
SVP, Clinical Development · Jul 30, 2014 – Feb 9, 2017 · Past
Brigit RileyChief Scientific Officer · Sep 2, 2021 – Mar 15, 2023 · Past
All 21 people
PersonSeat
Jack Anthony ThriftInterim CFO · Sep 2, 2021 – Sep 2, 2021 · Past
Julie ClarkChief Medical Officer · Jun 1, 2021 – Sep 30, 2021 · Past
Mark L Lupher JrDirector · Since at least May 1, 2019
Nancy E PecotaPrincipal Accounting Officer · Jun 6, 2022 – Jun 6, 2022 · Past
Peter SoparkarCHIEF OPERATING OFFICER · Since at least Feb 16, 2021
Rupert D'SouzaChief Financial Officer · Dec 6, 2021 – May 13, 2022 · Past
Setareh SeyedkazemiCHIEF DEVELOPMENT OFFICER · Since at least Jan 6, 2022
Soo HongDirector · Since at least Jun 17, 2025
Steven Daniel SchwartzDirector · Jul 30, 2014 – Jun 12, 2017 · Past
Szilard KissDirector · Since at least Jun 10, 2024
Thomas W ChalbergChief Executive Officer, Director · Jul 30, 2014 – Jun 10, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Adverum Biotechnologies Inc.